GT Medical Technologies Names Dr. Michael A. Garcia
as Chief Medical Officer
GT Medical Technologies Announces 2022 GammaTile® ELITE Brain Tumor Centers
GT Medical Technologies, Inc. announced its latest roster of ELITE Brain Tumor Centers that have received the distinction for completing 10 or more GammaTile Therapy procedures in 2022.
GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors
Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial
Doctors at UofL Health first in the state to use GammaTile Therapy
Doctors at UofL Health are the first in the state to use a new brain cancer radiation treatment called the gamma tile.
The 24 best medical device innovations of 2022
GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.
Kettering Health to offer new therapy that makes fighting brain tumors easier
Kettering Health is now the first provider in the Dayton area to offer GammaTile Therapy.
Glioblastoma Awareness Day
Today is Glioblastoma Awareness Day
Posted at 5:54 PM, Jul 20, 2022 and last updated 5:54 PM, Jul 20, 2022
Today is Glioblastoma Awareness Day, a day to help those affected by this devastating disease and remember lives lost to Glioblastoma (GMB), lives like Senator John McCain, and Mike Traphagen.
For his invention of GammaTile® Therapy used to treat operable brain tumors, David Brachman, M.D. is the 2022 winner of the Mensa Foundation’s Copper Black Award for Creative Achievement.
Tampa General Hospital Offers New Treatment for Recurrent Brain Cancer to Improve Quality of Life
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients experiencing recurring brain tumors a groundbreaking treatment.